Spots Global Cancer Trial Database for chemotherapeutic toxicity
Every month we try and update this database with for chemotherapeutic toxicity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Effectiveness of Mobile Based Monitoring System in the Management of Chemotherapy-Related Symptoms | NCT05946070 | Cancer Chemotherapeuti... Mobile Applicat... | ONKOSIS | 18 Years - | Istanbul University - Cerrahpasa (IUC) | |
App for Adverse Events to Oral Chemotherapy - Pilot Study | NCT05743686 | Breast Neoplasm... Chemotherapeuti... | Application | 18 Years - | CHU de Quebec-Universite Laval | |
Danish Elder Lymphoma Patient Hematopoietic Investigation | NCT05245487 | Lymphoma Chemotherapy-in... Chemotherapy-Re... Chemotherapeuti... | DNA repair gene... | 60 Years - | Rigshospitalet, Denmark | |
A Study of Apatinib Treatment in for Advanced Ovarian Cancer | NCT03393507 | Ovarian Cancer Chemotherapeuti... | Apatinib Taxus + platinu... | 18 Years - 75 Years | The People's Hospital of Leshan | |
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer | NCT05921149 | Ovarian Cancer Chemotherapeuti... | Fasting Mimicki... Carboplatin Paclitaxel Standard diet | 18 Years - | NorthShore University HealthSystem | |
System for High-Intensity Evaluation During Radiotherapy | NCT04277650 | Radiation Thera... Chemotherapeuti... | Machine learnin... | 18 Years - | Duke University | |
Diminish Chemotherapy Related Side Effects Through Patient Education | NCT04694794 | Chemotherapeuti... Chemotherapeuti... Chemotherapy Ef... | Educational Bro... | 18 Years - | Milton S. Hershey Medical Center | |
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC | NCT03792269 | Colorectal Canc... Chemotherapy Ef... Chemotherapeuti... | Irinotecan Oxaliplatin Capecitabine | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction | NCT05892146 | Chemotherapeuti... Cardiotoxicity Heart Failure Breast Cancer Lymphoma | Prevention ther... Rescue therapy | 20 Years - 65 Years | National Cheng-Kung University Hospital | |
Prevention of Chest Pain in Chemo-treated Cancer Patients | NCT03486340 | Solid Carcinoma 5-Fluorouracil ... Cardiotoxicity Chemotherapeuti... Acute Coronary ... Coronary Artery... Chest Pain | Cardiologic ass... | 18 Years - | Vejle Hospital | |
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum | NCT05512676 | Ovarian Neoplas... Chemotherapeuti... Chemotherapy Ef... Chemotherapy-in... Chemotherapy-in... | 18 Years - 80 Years | Oslo University Hospital | ||
The Effects of a Nurse-led mHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy | NCT05192525 | Breast Cancer Chemotherapeuti... | mChemotherapy | 18 Years - | The Hong Kong Polytechnic University | |
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | NCT05809557 | Oncology Chemotherapeuti... Metastatic Soli... | Chemotherapy to... Oncology Consul... | 65 Years - | Masonic Cancer Center, University of Minnesota | |
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® | NCT01735175 | Neutropenic Com... Breast Neoplasm... Chemotherapy-in... Chemotherapeuti... | LA-EP2006 Neulasta® | 18 Years - | Sandoz | |
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications | NCT04053439 | Lymphoma Chemotherapeuti... | Blood test for ... | 60 Years - | Sunnybrook Health Sciences Centre | |
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer | NCT03229096 | Chemotherapy Ef... Chemotherapeuti... Gastric Cancer | Apatinib plus X... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life | NCT06012253 | Chemotherapeuti... | Home Based Walk... | 18 Years - | Akdeniz University Hospital | |
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil | NCT05959720 | Acute Lymphoid ... Minimal Residua... Gene Abnormalit... Chemotherapeuti... | Prednisone Vincristin Daunorubicin Peg-asparaginas... Intrathecal Sus... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin | 16 Years - 50 Years | Instituto do Cancer do Estado de São Paulo | |
Understanding CARdiac Events in Breast Cancer | NCT05921279 | Breast Cancer Cardiotoxicity Cardiomyopathie... Chemotherapeuti... Heart Failure Oncology | 18 Years - 90 Years | National University of Ireland, Galway, Ireland | ||
Myocardial Perfusion and Fibrosis in Cancer Survivors | NCT03191461 | Myocardial Fibr... Myocardial Inju... Chemotherapeuti... | Adenosine stres... | 21 Years - 85 Years | Virginia Commonwealth University | |
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025 | NCT05417737 | Radiation Toxic... Chemotherapeuti... Chemotherapy-in... Delayed Wound H... Chronic Pain Refractory Pain | Ozone therapy | 18 Years - | Dr. Negrin University Hospital | |
Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer | NCT05921149 | Ovarian Cancer Chemotherapeuti... | Fasting Mimicki... Carboplatin Paclitaxel Standard diet | 18 Years - | NorthShore University HealthSystem | |
Serial PET MPI in Patients Undergoing Cancer Treatment | NCT05913999 | Cancer Chemotherapeuti... Coronary Artery... Coronary Microv... | 18 Years - | University of California, Los Angeles | ||
App for Adverse Events to Oral Chemotherapy - Pilot Study | NCT05743686 | Breast Neoplasm... Chemotherapeuti... | Application | 18 Years - | CHU de Quebec-Universite Laval | |
Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. | NCT06387901 | Breast Cancer Paclitaxel Adve... Chemotherapeuti... Chemotherapeuti... Body Weight Physical Inacti... | Paclitaxel Chem... | 18 Years - | Universitair Ziekenhuis Brussel | |
Neurovascular Changes Induced by Chemotherapy | NCT03339804 | Breast Cancer Chemotherapeuti... | Chemotherapy | 35 Years - 65 Years | University of Sao Paulo General Hospital | |
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
Machine Learning to Predict Acute Care During Cancer Therapy | NCT05122247 | Chemotherapeuti... | Machine learnin... | 18 Years - | Duke University | |
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | NCT03210298 | Peritoneum Canc... Peritoneum Neop... Pleural Cancer Pleural Effusio... Pleural Mesothe... Ovarian Cancer Gastric Cancer Appendix Cancer Pseudomyxoma Pe... Colorectal Canc... Pancreas Cancer Gallbladder Can... Ascites CUP Chemotherapeuti... | PIPAC | 10 Years - | University of Magdeburg | |
Role of Renal Biopsy in the Suspicion of Nephrotoxicity of Immunotherapy (Checkpoint Inhibitors) in Solid Cancer | NCT06357871 | Chemotherapeuti... | No intervention | 18 Years - | Central Hospital, Nancy, France | |
GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients | NCT03869294 | Pancreatic Canc... Chemotherapy Ef... Chemotherapeuti... | GS | 18 Years - 80 Years | Zhejiang University | |
Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD | NCT05137860 | Acute Lymphobla... Chemotherapeuti... Minimal Residua... | Bortezomib | 18 Years - 50 Years | Hospital General de Mexico | |
Tolerance of Anti-Cancer Therapy in the Elderly | NCT05251922 | Frailty Chemotherapeuti... | 65 Years - | The Leeds Teaching Hospitals NHS Trust | ||
Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome | NCT04754672 | Colorectal Canc... Chemotherapeuti... Survivorship Lifestyle | Continuous aero... Continuous aero... | 18 Years - | Radboud University Medical Center | |
Neurovascular Changes Induced by Chemotherapy | NCT03339804 | Breast Cancer Chemotherapeuti... | Chemotherapy | 35 Years - 65 Years | University of Sao Paulo General Hospital | |
Sarcopenia and Visceral Obesity in Esophageal and Gastric Cancer | NCT03061370 | Esophageal Canc... Gastric Cancer Sarcopenia Sarcopenic Obes... Obesity Visceral Obesit... Quality of Life Surgery Complication of... Chemotherapeuti... Physical Activi... Oncology | Esophagectomy o... | 18 Years - | St. James's Hospital, Ireland | |
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® | NCT01735175 | Neutropenic Com... Breast Neoplasm... Chemotherapy-in... Chemotherapeuti... | LA-EP2006 Neulasta® | 18 Years - | Sandoz | |
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications | NCT04053439 | Lymphoma Chemotherapeuti... | Blood test for ... | 60 Years - | Sunnybrook Health Sciences Centre | |
Rituximab Combined With Chidamide and Lenalidomide for r/r AITL | NCT04319601 | Angioimmunoblas... Chemotherapy Ef... Chemotherapeuti... | Rituximab | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively | NCT05840575 | Chemotherapy-Re... Chemotherapeuti... Chemo-brain Cancer Childhood Cance... Hodgkin Lymphom... Non Hodgkin Lym... Testicular Canc... Sarcoma Leukemia | 7 Years - 29 Years | Rigshospitalet, Denmark | ||
Effects of Exercise Training in Survivors of Lymphoma | NCT06270667 | Lymphoma Physical Exerci... Cardiotoxicity Cardiovascular ... Chemotherapeuti... | Aerobic Exercis... Combined Aerobi... | 20 Years - 70 Years | Norwegian School of Sport Sciences | |
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer | NCT05461261 | Hormone Sensiti... DNA Damage Repa... Chemotherapy Ef... Chemotherapeuti... | Docetaxel Prednisolone Ac... Platinum-based ... | 40 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. | NCT06387901 | Breast Cancer Paclitaxel Adve... Chemotherapeuti... Chemotherapeuti... Body Weight Physical Inacti... | Paclitaxel Chem... | 18 Years - | Universitair Ziekenhuis Brussel | |
Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. | NCT06387901 | Breast Cancer Paclitaxel Adve... Chemotherapeuti... Chemotherapeuti... Body Weight Physical Inacti... | Paclitaxel Chem... | 18 Years - | Universitair Ziekenhuis Brussel | |
Prevention of Chest Pain in Chemo-treated Cancer Patients | NCT03486340 | Solid Carcinoma 5-Fluorouracil ... Cardiotoxicity Chemotherapeuti... Acute Coronary ... Coronary Artery... Chest Pain | Cardiologic ass... | 18 Years - | Vejle Hospital | |
Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil | NCT05959720 | Acute Lymphoid ... Minimal Residua... Gene Abnormalit... Chemotherapeuti... | Prednisone Vincristin Daunorubicin Peg-asparaginas... Intrathecal Sus... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin | 16 Years - 50 Years | Instituto do Cancer do Estado de São Paulo | |
Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage | NCT05731375 | Doxorubicin Ind... Chemotherapeuti... B-cell Lymphoma T-cell Lymphoma | 31-MRS at 7 Tes... | 18 Years - | UMC Utrecht | |
Symptoms Associated With Chemotherapy-Induced Peripheral Neuropathy | NCT06352567 | Chemotherapy-in... Breast Cancer Breast Cancer F... | European Organi... | 18 Years - 80 Years | Izmir Bakircay University | |
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy | NCT04495387 | Colon Cancer Breast Cancer Chemotherapeuti... | Chemotherapy | 18 Years - 80 Years | University of Florence | |
Myocardial Perfusion and Fibrosis in Cancer Survivors | NCT03191461 | Myocardial Fibr... Myocardial Inju... Chemotherapeuti... | Adenosine stres... | 21 Years - 85 Years | Virginia Commonwealth University | |
Alpha-Lipoic Acid in Breast Cancer Patients | NCT03908528 | Breast Cancer Chemotherapeuti... | Alpha-lipoic ac... Placebo Plus Ch... | 18 Years - 70 Years | Damanhour University | |
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer | NCT03785704 | Breast Neoplasm... Cardiac Event Chemotherapeuti... | Xinmailong Inje... | 18 Years - | Peking Union Medical College | |
Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy | NCT03039062 | Chemotherapeuti... Malignant Tumor Liver Injury | 18 Years - 70 Years | ChineseAMS | ||
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity | NCT05809557 | Oncology Chemotherapeuti... Metastatic Soli... | Chemotherapy to... Oncology Consul... | 65 Years - | Masonic Cancer Center, University of Minnesota | |
Daily Hand-Held Vibration Therapy | NCT04207437 | Neuropathy Cancer Chemotherapeuti... Chemotherapeuti... | Vibration thera... | 18 Years - | Indiana University | |
Neurovascular Changes Induced by Chemotherapy | NCT03339804 | Breast Cancer Chemotherapeuti... | Chemotherapy | 35 Years - 65 Years | University of Sao Paulo General Hospital | |
The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis | NCT04988971 | Mucositis Chemotherapeuti... | a compound glut... a compound glut... | 18 Years - 75 Years | West China Hospital | |
Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer | NCT03785704 | Breast Neoplasm... Cardiac Event Chemotherapeuti... | Xinmailong Inje... | 18 Years - | Peking Union Medical College | |
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | NCT03566394 | Invasive Breast... Chemotherapeuti... Myalgia Arthralgia | Gabapentin 300m... | 18 Years - | British Columbia Cancer Agency | |
Pedaling at a Low-Moderate Intensity During Chemotherapy Administration | NCT04258969 | Colorectal Canc... Exercise, Aerob... Chemotherapy Chemotherapeuti... | Pedaling | 18 Years - | Rush University Medical Center | |
Rituximab Combined With Chidamide and Lenalidomide for r/r AITL | NCT04319601 | Angioimmunoblas... Chemotherapy Ef... Chemotherapeuti... | Rituximab | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
Symptoms Associated With Chemotherapy-Induced Peripheral Neuropathy | NCT06352567 | Chemotherapy-in... Breast Cancer Breast Cancer F... | European Organi... | 18 Years - 80 Years | Izmir Bakircay University | |
Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications | NCT04053439 | Lymphoma Chemotherapeuti... | Blood test for ... | 60 Years - | Sunnybrook Health Sciences Centre | |
Effects of Exercise Training in Survivors of Lymphoma | NCT06270667 | Lymphoma Physical Exerci... Cardiotoxicity Cardiovascular ... Chemotherapeuti... | Aerobic Exercis... Combined Aerobi... | 20 Years - 70 Years | Norwegian School of Sport Sciences | |
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function | NCT04799080 | Cancer Chemotherapy-in... Chemotherapeuti... Breast Cancer Breast Neoplasm... Colon Neoplasm Colo-rectal Can... | 18 Years - 85 Years | Izmir Bakircay University | ||
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial | NCT02996201 | Adverse Event Cancer, Breast Chemotherapeuti... Patient Outcome... | Completion of P... | 18 Years - | Rigshospitalet, Denmark | |
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction | NCT05892146 | Chemotherapeuti... Cardiotoxicity Heart Failure Breast Cancer Lymphoma | Prevention ther... Rescue therapy | 20 Years - 65 Years | National Cheng-Kung University Hospital | |
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function | NCT04799080 | Cancer Chemotherapy-in... Chemotherapeuti... Breast Cancer Breast Neoplasm... Colon Neoplasm Colo-rectal Can... | 18 Years - 85 Years | Izmir Bakircay University | ||
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients. | NCT05635929 | Oral Mucositis Quality of Life Mucositis Pain Speech Saliva Radiation Toxic... Chemotherapeuti... | Composition com... | 18 Years - | Mucosa Innovations, S.L. | |
Effectiveness of Mobile Based Monitoring System in the Management of Chemotherapy-Related Symptoms | NCT05946070 | Cancer Chemotherapeuti... Mobile Applicat... | ONKOSIS | 18 Years - | Istanbul University - Cerrahpasa (IUC) | |
C677T and A1298C MTHFR Polymorphisms and Fluoropyrimidine Effectiveness in Metastatic Colon Cancer | NCT03852290 | Colon Cancer MTHFR Gene Muta... Chemotherapeuti... Chemotherapy Ef... | 18 Years - | Universidad de Costa Rica | ||
Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® | NCT01735175 | Neutropenic Com... Breast Neoplasm... Chemotherapy-in... Chemotherapeuti... | LA-EP2006 Neulasta® | 18 Years - | Sandoz | |
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC | NCT03061058 | Stomach Neoplas... Chemotherapy Ef... Chemotherapeuti... | Docetaxel Oxaliplatin Cisplatin Irinotecan Pemetrexed S1 | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy | NCT04632797 | Chemotherapy-in... Chemotherapeuti... Chemotherapeuti... | Hilotherm Chemo... | 18 Years - 99 Years | Medical University Innsbruck | |
Symptoms Associated With Chemotherapy-Induced Peripheral Neuropathy | NCT06352567 | Chemotherapy-in... Breast Cancer Breast Cancer F... | European Organi... | 18 Years - 80 Years | Izmir Bakircay University | |
AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer | NCT05302336 | Breast Cancer Chemotherapeuti... | Liposomal doxor... | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer | NCT05461261 | Hormone Sensiti... DNA Damage Repa... Chemotherapy Ef... Chemotherapeuti... | Docetaxel Prednisolone Ac... Platinum-based ... | 40 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients. | NCT05635929 | Oral Mucositis Quality of Life Mucositis Pain Speech Saliva Radiation Toxic... Chemotherapeuti... | Composition com... | 18 Years - | Mucosa Innovations, S.L. |